부산대학교 도서관

Armand, Ray ; Channon, Jacqueline Y ; Kintner, Jennifer ; White, Kristina A ; Miselis, Kristin A ; Perez, Raymond P ; Lewis, Lionel D

In Toxicology and Applied Pharmacology 2004 196(1):68-79

Pipas, J.Marc ; Mitchell, Sandra E ; Barth, Richard J, Jr ; Vera-Gimon, Raul ; Rathmann, Joerg ; Meyer, Louise P ; Wagman, Richard S ; Lewis, Lionel D ; McDonnell, Carol ; Colacchio, Thomas A ; Perez, Raymond P

In International Journal of Radiation Oncology, Biology, Physics 2001 50(5):1317-1322

Perez, Raymond P ; Zhang, Paul J.L

In Human Pathology 1999 30(2):239-242

Komiya T; Division of Medical Oncology, University of Kansas Medical Center, KS, USA.; Perez RP; Division of Medical Oncology, University of Kansas Medical Center, KS, USA.; Yamamoto S; Division of Medical Oncology, University of Kansas Medical Center, KS, USA.; Neupane P; Division of Medical Oncology, University of Kansas Medical Center, KS, USA.

Publisher: Blackwell Publishing Country of Publication: England NLM ID: 101315570 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1752-699X (Electronic) Linking ISSN: 17526981 NLM ISO Abbreviation: Clin Respir J Subsets: MEDLINE

Moore KN; Department of Obstetrics and Gynecology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.; Borghaei H; Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania.; O'Malley DM; Department of Obstetrics and Gynecology, The Ohio State University College of Medicine, Columbus, Ohio.; Jeong W; Cancer Therapy and Research Center, University of Texas Health Science Center, San Antonio, Texas.; Seward SM; Department of Obstetrics and Gynecology, Wayne State University, Detroit, Michigan.; Bauer TM; Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Nashville, Tennessee.; Perez RP; Division of Hematology/Oncology, University of Kansas, Fairway, Kansas.; Matulonis UA; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts.; Running KL; ImmunoGen, Inc., Waltham, Massachusetts.; Zhang X; ImmunoGen, Inc., Waltham, Massachusetts.; Ponte JF; ImmunoGen, Inc., Waltham, Massachusetts.; Ruiz-Soto R; ImmunoGen, Inc., Waltham, Massachusetts.; Birrer MJ; Gillette Center for Gynecologic Oncology, Massachusetts General Hospital, Boston, Massachusetts.

Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE

Kim ES; City of Hope Orange County and National Medical Center, Los Angeles, California. edwkim@coh.org.; Uldrick TS; Fred Hutchinson Cancer Research Center, Seattle, Washington.; Schenkel C; American Society of Clinical Oncology, Alexandria, Virginia.; Bruinooge SS; American Society of Clinical Oncology, Alexandria, Virginia.; Harvey RD; Emory University School of Medicine, Atlanta, Georgia.; Magnuson A; University of Rochester, Rochester, New York.; Spira A; Virginia Cancer Specialists PC, Fairfax, Virginia.; Wade JL; Cancer Care Specialists of Illinois, Decatur, Illinois.; Stewart MD; Friends of Cancer Research, Washington, DC.; Vega DM; Friends of Cancer Research, Washington, DC.; Beaver JA; U.S. Food and Drug Administration, Silver Spring, Maryland.; Denicoff AM; National Cancer Institute, Bethesda, Maryland.; Ison G; U.S. Food and Drug Administration, Silver Spring, Maryland.; Ivy SP; National Cancer Institute, Bethesda, Maryland.; George S; Dana-Farber Cancer Institute, Boston, Massachusetts.; Perez RP; Bristol-Myers Squibb, Lawrenceville, New Jersey.; Spears PA; UNC Patient Advocates for Research Council, Raleigh, North Carolina.; Tap WD; Memorial Sloan Kettering Cancer Center, New York, New York.; Schilsky RL; American Society of Clinical Oncology, Alexandria, Virginia.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Perez RP; Division of Hematology/Oncology, University of Kansas Medical Center, Kansas City.; Komiya T; Division of Hematology/Oncology, University of Kansas Medical Center, Kansas City.

Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited Medium: Internet ISSN: 1538-3598 (Electronic) Linking ISSN: 00987484 NLM ISO Abbreviation: JAMA Subsets: MEDLINE

Goldstein LJ; Department of Medical Oncology, The Hospital of Fox Chase Cancer Center, Philadelphia, PA, USA.; Perez RP; University of Kansas Medical Research Center, Fairway, KS, USA.; Current address: Early Oncology Development, Bristol-Myers Squibb, 3401 Princeton Pike, Lawrenceville, NJ, 08648, USA.; Yardley D; Tennessee Oncology, Nashville, TN, USA.; Sarah Cannon Research Institute, 250 25th Avenue North Suite 200, Nashville, TN, 37203, USA.; Han LK; Indiana University Simon Cancer Center, Indianapolis, IN, USA.; Current address: Parkview Cancer Institute, 11141 Parkview Plaza, Suite 305A, Fort Wayne, IN, 46845, USA.; Reuben JM; Department of Hematopathology-Research, MD Anderson Cancer Center, Houston, TX, USA.; Gao H; Department of Hematopathology-Research, MD Anderson Cancer Center, Houston, TX, USA.; McCanna S; Research and Development, Dompé farmaceutici S.p.A., 20122, Milan, Italy.; Butler B; Research and Development, Dompé farmaceutici S.p.A., 20122, Milan, Italy.; Ruffini PA; Research and Development, Dompé farmaceutici S.p.A., 20122, Milan, Italy.; Liu Y; The Methodist Hospital Research Institute, 6445 Main Street, Houston, TX, 77030, USA.; Rosato RR; The Methodist Hospital Research Institute, 6445 Main Street, Houston, TX, 77030, USA.; Chang JC; The Methodist Hospital Research Institute, 6445 Main Street, Houston, TX, 77030, USA. jcchang@houstonmethodist.org.

Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 100927353 Publication Model: Electronic Cited Medium: Internet ISSN: 1465-542X (Electronic) Linking ISSN: 14655411 NLM ISO Abbreviation: Breast Cancer Res Subsets: MEDLINE; PubMed not MEDLINE

Ghobrial IM; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. irene_ghobrial@dfci.harvard.edu.; Liu CJ; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Redd RA; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Perez RP; University of Kansas, Fairway, Kansas.; Baz R; Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.; Zavidij O; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Sklavenitis-Pistofidis R; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Richardson PG; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Anderson KC; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Laubach J; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Henrick P; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Savell A; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Reyes K; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Hornburg K; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Chuma S; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Sabbatini P; Bristol-Myers Squibb, Sunnyvale, California.; Bristol-Myers Squibb, Princeton, New Jersey.; Robbins MD; Bristol-Myers Squibb, Sunnyvale, California.; Bristol-Myers Squibb, Princeton, New Jersey.; Becker PS; University of Washington, Seattle, Washington.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Goldstein LJ; Department of Medical Oncology, The Hospital of Fox Chase Cancer Center, Philadelphia, PA, USA.; Perez RP; University of Kansas Medical Research Center, Fairway, KS, USA.; Current address: Early Oncology Development, Bristol-Myers Squibb, 3401 Princeton Pike, Lawrenceville, NJ, 08648, USA.; Yardley D; Tennessee Oncology, Nashville, TN, USA.; Han LK; Indiana University Simon Cancer Center, Indianapolis, IN, USA.; Current address: Parkview Cancer Institute, 11141 Parkview Plaza, Suite 305A, Fort Wayne, IN, 46845, USA.; Reuben JM; Department of Hematopathology-Research, MD Anderson Cancer Center, Houston, TX, USA.; Gao H; Department of Hematopathology-Research, MD Anderson Cancer Center, Houston, TX, USA.; McCanna S; Research and Development, Dompé farmaceutici S.p.A., 20122, Milan, Italy.; Butler B; Research and Development, Dompé farmaceutici S.p.A., 20122, Milan, Italy.; Ruffini PA; Research and Development, Dompé farmaceutici S.p.A., 20122, Milan, Italy.; Liu Y; The Methodist Hospital Research Institute, 6445 Main Street, Houston, TX, 77030, USA.; Rosato RR; The Methodist Hospital Research Institute, 6445 Main Street, Houston, TX, 77030, USA.; Chang JC; The Methodist Hospital Research Institute, 6445 Main Street, Houston, TX, 77030, USA. jcchang@houstonmethodist.org.

Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 100927353 Publication Model: Electronic Cited Medium: Internet ISSN: 1465-542X (Electronic) Linking ISSN: 14655411 NLM ISO Abbreviation: Breast Cancer Res Subsets: MEDLINE

Mileham KF; Levine Cancer Institute, Atrium Health Charlotte NC.; Schenkel C; American Society of Clinical Oncology, Alexandria, VA.; Chuk MK; US Food and Drug Administration, Silver Spring, MD.; Buchmeier A; Sarah Cannon Cancer Center, Nashville, TN.; Perez RP; Bristol-Myers Squibb, New York, NY.; Hurley P; American Society of Clinical Oncology, Alexandria, VA.; Levit LA; American Society of Clinical Oncology, Alexandria, VA.; Garrett-Mayer E; American Society of Clinical Oncology, Alexandria, VA.; Davis C; American Society of Clinical Oncology, Alexandria, VA.; Bruinooge SS; American Society of Clinical Oncology, Alexandria, VA.; Vose J; University of Nebraska Medical Center, Omaha, NE.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101261852 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1935-469X (Electronic) Linking ISSN: 15547477 NLM ISO Abbreviation: J Oncol Pract Subsets: MEDLINE

Perez RP; University of Kansas Clinical Research Center Fairway KS USA.; Chen E; Department of Medical Oncology and Hematology Princess Margaret Hospital Toronto ON Canada.; Thaddeus Beck J; Highlands Oncology Group Fayetteville AR USA.; Shirai K; Dartmouth-Hitchcock Medical Center Lebanon NH USA.; Neil Hayes D; University of North Carolina at Chapel Hill Chapel Hill NC USA.; Shen T; Eli Lilly and Company Indianapolis IN USA.; Baldwin JR; Eli Lilly and Company Indianapolis IN USA.; Bryant KB; Eli Lilly and Company Indianapolis IN USA.; He S; Eli Lilly and Company Indianapolis IN USA.; Chin S; Eli Lilly and Company Indianapolis IN USA.

Publisher: John Wiley & Sons Ltd, British Pharmacological Society and American Society for Pharmacology and Experimental Therapeutics Country of Publication: United States NLM ID: 101626369 Publication Model: eCollection Cited Medium: Internet ISSN: 2052-1707 (Electronic) Linking ISSN: 20521707 NLM ISO Abbreviation: Pharmacol Res Perspect Subsets: MEDLINE

Eastman A; Department of Pharmacology and Toxicology, Dartmouth Medical School, Norris Cotton Cancer Center, Lebanon, NH 03756, USA. alan.r.eastman@dartmouth.edu; Perez RP

Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7503323 Publication Model: Print Cited Medium: Print ISSN: 0306-5251 (Print) Linking ISSN: 03065251 NLM ISO Abbreviation: Br J Clin Pharmacol Subsets: MEDLINE

Ramanathan RK; Division of Hematology/Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA. ramanathanrk@upmc.edu; Fakih M; Mani S; Deutsch M; Perez RP; Ritter MA; Eiseman JL; Ivy SP; Trump DL; Belani CP; Parise RA; Potter DM; Egorin MJ

Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0344-5704 (Print) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE

Levit LA; Laura A. Levit and Richard L. Schilsky, American Society of Clinical Oncology, Alexandria, VA; Raymond P. Perez, Bristol-Myers Squibb, Lawrence Township, NJ; David C. Smith and Daniel F. Hayes, University of Michigan, Ann Arbor, MI; and Julie M. Vose, University of Nebraska Medical Center, Omaha, NE.; Perez RP; Laura A. Levit and Richard L. Schilsky, American Society of Clinical Oncology, Alexandria, VA; Raymond P. Perez, Bristol-Myers Squibb, Lawrence Township, NJ; David C. Smith and Daniel F. Hayes, University of Michigan, Ann Arbor, MI; and Julie M. Vose, University of Nebraska Medical Center, Omaha, NE.; Smith DC; Laura A. Levit and Richard L. Schilsky, American Society of Clinical Oncology, Alexandria, VA; Raymond P. Perez, Bristol-Myers Squibb, Lawrence Township, NJ; David C. Smith and Daniel F. Hayes, University of Michigan, Ann Arbor, MI; and Julie M. Vose, University of Nebraska Medical Center, Omaha, NE.; Schilsky RL; Laura A. Levit and Richard L. Schilsky, American Society of Clinical Oncology, Alexandria, VA; Raymond P. Perez, Bristol-Myers Squibb, Lawrence Township, NJ; David C. Smith and Daniel F. Hayes, University of Michigan, Ann Arbor, MI; and Julie M. Vose, University of Nebraska Medical Center, Omaha, NE.; Hayes DF; Laura A. Levit and Richard L. Schilsky, American Society of Clinical Oncology, Alexandria, VA; Raymond P. Perez, Bristol-Myers Squibb, Lawrence Township, NJ; David C. Smith and Daniel F. Hayes, University of Michigan, Ann Arbor, MI; and Julie M. Vose, University of Nebraska Medical Center, Omaha, NE.; Vose JM; Laura A. Levit and Richard L. Schilsky, American Society of Clinical Oncology, Alexandria, VA; Raymond P. Perez, Bristol-Myers Squibb, Lawrence Township, NJ; David C. Smith and Daniel F. Hayes, University of Michigan, Ann Arbor, MI; and Julie M. Vose, University of Nebraska Medical Center, Omaha, NE.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol

Martin LP; Fox Chase Cancer Center, Philadelphia, PA, United States. Electronic address: lainie.martin@fccc.edu.; Konner JA; Memorial Sloan Kettering Cancer Center, New York, NY, United States. Electronic address: konnerj@MSKCC.org.; Moore KN; Stephenson Oklahoma Cancer Center at the University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States. Electronic address: kathleen-moore@ouhsc.edu.; Seward SM; Wayne State University - Karmanos Cancer Institute, Huntington Woods, MI, United States. Electronic address: sseward@med.wayne.edu.; Matulonis UA; Dana Farber Cancer Institute, Boston, MA, United States. Electronic address: ursula_matulonis@dfci.harvard.edu.; Perez RP; University of Kansas, Fairway, KS, United States. Electronic address: perezonc@gmail.com.; Su Y; ImmunoGen, Inc., Waltham, MA, United States. Electronic address: ying.su@immmunogen.com.; Berkenblit A; ImmunoGen, Inc., Waltham, MA, United States. Electronic address: anna.berkenblit@immunogen.com.; Ruiz-Soto R; ImmunoGen, Inc., Waltham, MA, United States. Electronic address: rodrigo.ruizsoto@gmail.com.; Birrer MJ; Massachusetts General Hospital, Boston, MA, United States. Electronic address: mbirrer@mgh.harvard.edu.

Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-6859 (Electronic) Linking ISSN: 00908258 NLM ISO Abbreviation: Gynecol Oncol Subsets: MEDLINE

Komiya T; Division of Medical Oncology, University of Kansas Medical Center, Fairway, KS, USA.; Section of Hematology/Oncology, Tulane University School of Medicine, New Orleans, LA, USA.; Yamamoto S; Division of Medical Oncology, University of Kansas Medical Center, Fairway, KS, USA.; Roy A; High Throughput Screening Facility, University of Kansas School of Pharmacy, Lawrence, KS, USA.; McDonald P; High Throughput Screening Facility, University of Kansas School of Pharmacy, Lawrence, KS, USA.; Perez RP; Division of Medical Oncology, University of Kansas Medical Center, Fairway, KS, USA.

Publisher: Pioneer Bioscience Publishing Company Country of Publication: China NLM ID: 101646875 Publication Model: Print Cited Medium: Print ISSN: 2218-6751 (Print) Linking ISSN: 22186751 NLM ISO Abbreviation: Transl Lung Cancer Res Subsets: PubMed not MEDLINE

Schott AF; Comprehensive Cancer Center, University of Michigan, Ann Arbor, Michigan. aschott@umich.edu.; Goldstein LJ; Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania.; Cristofanilli M; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois.; Ruffini PA; Project Management, Dompé Farmaceutici S.p.A., Milano, Italy.; McCanna S; Project Management, Dompé Farmaceutici S.p.A., Milano, Italy.; Reuben JM; Department of Hematopathology - Research, MD Anderson Cancer Center, Houston, Texas.; Perez RP; University of Kansas Medical Center, Kansas City, Kansas.; Kato G; Pinnacle Oncology Hematology, Scottsdale, Arizona.; Wicha M; Comprehensive Cancer Center, University of Michigan, Ann Arbor, Michigan.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Moore KN; Kathleen N. Moore, University of Oklahoma Health Sciences Center, Oklahoma City, OK; Lainie P. Martin, Fox Chase Cancer Center, Philadelphia, PA; David M. O'Malley, Ohio State University James Cancer Center, Columbus, OH; Ursula A. Matulonis, Dana-Farber Cancer Institute; Michael J. Birrer, Massachusetts General Hospital, Boston; Rodrigo Ruiz-Soto, ImmunoGen, Waltham, MA; Jason A. Konner, Memorial Sloan Kettering Cancer Center, New York, NY; Raymond P. Perez, University of Kansas, Fairway, KS; and Todd M. Bauer, Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN.; Martin LP; Kathleen N. Moore, University of Oklahoma Health Sciences Center, Oklahoma City, OK; Lainie P. Martin, Fox Chase Cancer Center, Philadelphia, PA; David M. O'Malley, Ohio State University James Cancer Center, Columbus, OH; Ursula A. Matulonis, Dana-Farber Cancer Institute; Michael J. Birrer, Massachusetts General Hospital, Boston; Rodrigo Ruiz-Soto, ImmunoGen, Waltham, MA; Jason A. Konner, Memorial Sloan Kettering Cancer Center, New York, NY; Raymond P. Perez, University of Kansas, Fairway, KS; and Todd M. Bauer, Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN.; O'Malley DM; Kathleen N. Moore, University of Oklahoma Health Sciences Center, Oklahoma City, OK; Lainie P. Martin, Fox Chase Cancer Center, Philadelphia, PA; David M. O'Malley, Ohio State University James Cancer Center, Columbus, OH; Ursula A. Matulonis, Dana-Farber Cancer Institute; Michael J. Birrer, Massachusetts General Hospital, Boston; Rodrigo Ruiz-Soto, ImmunoGen, Waltham, MA; Jason A. Konner, Memorial Sloan Kettering Cancer Center, New York, NY; Raymond P. Perez, University of Kansas, Fairway, KS; and Todd M. Bauer, Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN.; Matulonis UA; Kathleen N. Moore, University of Oklahoma Health Sciences Center, Oklahoma City, OK; Lainie P. Martin, Fox Chase Cancer Center, Philadelphia, PA; David M. O'Malley, Ohio State University James Cancer Center, Columbus, OH; Ursula A. Matulonis, Dana-Farber Cancer Institute; Michael J. Birrer, Massachusetts General Hospital, Boston; Rodrigo Ruiz-Soto, ImmunoGen, Waltham, MA; Jason A. Konner, Memorial Sloan Kettering Cancer Center, New York, NY; Raymond P. Perez, University of Kansas, Fairway, KS; and Todd M. Bauer, Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN.; Konner JA; Kathleen N. Moore, University of Oklahoma Health Sciences Center, Oklahoma City, OK; Lainie P. Martin, Fox Chase Cancer Center, Philadelphia, PA; David M. O'Malley, Ohio State University James Cancer Center, Columbus, OH; Ursula A. Matulonis, Dana-Farber Cancer Institute; Michael J. Birrer, Massachusetts General Hospital, Boston; Rodrigo Ruiz-Soto, ImmunoGen, Waltham, MA; Jason A. Konner, Memorial Sloan Kettering Cancer Center, New York, NY; Raymond P. Perez, University of Kansas, Fairway, KS; and Todd M. Bauer, Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN.; Perez RP; Kathleen N. Moore, University of Oklahoma Health Sciences Center, Oklahoma City, OK; Lainie P. Martin, Fox Chase Cancer Center, Philadelphia, PA; David M. O'Malley, Ohio State University James Cancer Center, Columbus, OH; Ursula A. Matulonis, Dana-Farber Cancer Institute; Michael J. Birrer, Massachusetts General Hospital, Boston; Rodrigo Ruiz-Soto, ImmunoGen, Waltham, MA; Jason A. Konner, Memorial Sloan Kettering Cancer Center, New York, NY; Raymond P. Perez, University of Kansas, Fairway, KS; and Todd M. Bauer, Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN.; Bauer TM; Kathleen N. Moore, University of Oklahoma Health Sciences Center, Oklahoma City, OK; Lainie P. Martin, Fox Chase Cancer Center, Philadelphia, PA; David M. O'Malley, Ohio State University James Cancer Center, Columbus, OH; Ursula A. Matulonis, Dana-Farber Cancer Institute; Michael J. Birrer, Massachusetts General Hospital, Boston; Rodrigo Ruiz-Soto, ImmunoGen, Waltham, MA; Jason A. Konner, Memorial Sloan Kettering Cancer Center, New York, NY; Raymond P. Perez, University of Kansas, Fairway, KS; and Todd M. Bauer, Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN.; Ruiz-Soto R; Kathleen N. Moore, University of Oklahoma Health Sciences Center, Oklahoma City, OK; Lainie P. Martin, Fox Chase Cancer Center, Philadelphia, PA; David M. O'Malley, Ohio State University James Cancer Center, Columbus, OH; Ursula A. Matulonis, Dana-Farber Cancer Institute; Michael J. Birrer, Massachusetts General Hospital, Boston; Rodrigo Ruiz-Soto, ImmunoGen, Waltham, MA; Jason A. Konner, Memorial Sloan Kettering Cancer Center, New York, NY; Raymond P. Perez, University of Kansas, Fairway, KS; and Todd M. Bauer, Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN.; Birrer MJ; Kathleen N. Moore, University of Oklahoma Health Sciences Center, Oklahoma City, OK; Lainie P. Martin, Fox Chase Cancer Center, Philadelphia, PA; David M. O'Malley, Ohio State University James Cancer Center, Columbus, OH; Ursula A. Matulonis, Dana-Farber Cancer Institute; Michael J. Birrer, Massachusetts General Hospital, Boston; Rodrigo Ruiz-Soto, ImmunoGen, Waltham, MA; Jason A. Konner, Memorial Sloan Kettering Cancer Center, New York, NY; Raymond P. Perez, University of Kansas, Fairway, KS; and Todd M. Bauer, Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

Perez RP; The University of Kansas Cancer Center, Kansas City, KS, United States.; Finnigan S; National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.; Patel K; Merck Research Laboratories, Sudbury, MA, United States.; Whitney S; Eli Lilly and Company, Indianapolis, IN, United States.; Forrest A; Clinical Trials Transformation Initiative, Durham, NC, United States.

Publisher: JMIR Publications Country of Publication: Canada NLM ID: 101666844 Publication Model: Electronic Cited Medium: Print ISSN: 2369-1999 (Print) Linking ISSN: 23691999 NLM ISO Abbreviation: JMIR Cancer Subsets: PubMed not MEDLINE